The Children’s Hospitals Neonatal Consortium (CHNC) improves care for high-risk infants by providing a platform to compare quality and outcomes across Level IV neonatal intensive care units (NICUs).
The CHNC Annual Symposium brings together key stakeholders to further improve care for the infant patient population in the highest level NICUs in North America. The aim is to rapidly convert research from the CHNC database as well as experience and collaboration of the CHNC membership to clinical bedside care for the NICU patients and their families. Renowned national experts will speak about current evidence and practice in quaternary neonatology clinical problems, including this year’s focus on genetics, family impact of neonatal care, current approaches to gastroschisis, and incorporating anti-racism in the NICU. Workshops will lead practical sessions addressing some of the most common issues in NICUs, ranging from general quality improvement education to care of infants with bronchopulmonary dysplasia.
Meet the CENTOGENE team at our booth from November 1 to 3 at Omni Houston Hotel (4 Riverway, Houston, TX 77056) and gain insights from one of the leaders in rare disease diagnostics.
Read more about the CHNC Annual Symposium on the event page.
Want to know more about CENTOGENE?
Book a meeting in advance with us by contacting Patrick Navarro.